Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Crypto Analyst Predicts Bitcoin Price Will Reach ‘$150,000 by December 15th, 2021’ – CryptoGlobe
Article feature image
Judge Blocks CDC From Enforcing Cruise Ship Coronavirus Rules – HuffPost
Article feature image
A fantasy league bet that ended with 15-hour Waffle House trip – ESPN